BLOOD CELL TECHNOLOGIES, LLC: Development of Second Generation BLVRB Inhibitors for Treating Chemotherapy Induced Thrombocytopenia
BLOOD CELL TECHNOLOGIES, LLC (Stony Brook, New York): Development of Second Generation BLVRB Inhibitors for Treating Chemotherapy Induced Thrombocytopenia. Its award of $875,125 is above the median of $407,048 (84th percentile). Dated 48 days ago, it serves as a historical benchmark. Score 55/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $875,125 · 84th percentile of 10,712 NihBiotechGrantPulse records · 2.1x the median
Free preview: all 10 published fields of this record are shown below. Locked: 499 related NY NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | BLOOD CELL TECHNOLOGIES, LLC |
| Location | Stony Brook, NY |
| Project | Development of Second Generation BLVRB Inhibitors for Treating Chemotherapy Induced Thrombocytopenia |
| Project number | 4R44CA302180-02 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $875,125 |
| Awarded | 2026-09-17 |
| Project period | 2025-09-01 to 2028-08-31 |
| UEI | HH9LT9M9B3N4 |
| award percentile | 84th of 10,712 (median $407,048, 2.1x median) |
| Peer records CSV (500 NY records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch BLOOD CELL TECHNOLOGIES, LLC
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock BLOOD CELL TECHNOLOGIES + 500 NY peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-17
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (NY first): NEW YORK UNIVERSITY SCHOOL OF MEDICINE · UNIVERSITY OF ROCHESTER · NEW YORK UNIVERSITY · WEILL MEDICAL COLL OF CORNELL UNIV · CORNELL UNIVERSITY · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: BLOOD CELL TECHNOLOGIES, LLC and 851 New York peers
- New York NihBiotechGrantPulse records like this one: 851
- BLOOD CELL TECHNOLOGIES, LLC's award: 84th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every New York peer: $170,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
55 / 100 Lab Budget Score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for BLOOD CELL TECHNOLOGIES, LLC in Stony Brook, New York?
BLOOD CELL TECHNOLOGIES, LLC received an NIH award of $875,125 on 2026-09-17: Development of Second Generation BLVRB Inhibitors for Treating Chemotherapy Induced Thrombocytopenia.
How does BLOOD CELL TECHNOLOGIES, LLC compare to other New York NihBiotechGrantPulse records?
Its award of $875,125 sits in the upper half (84th percentile) of 10,712 records; the median is $407,048. It is 48 days old; check the official source for later updates before acting.
BLOOD CELL TECHNOLOGIES, LLC vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| BLOOD CELL TECHNOLOGIES, LLC | Stony Brook, NY | 875,125 | 84th | 2026-09-17 |
| DUB THERAPEUTICS INC. | SYRACUSE, NY | 1,009,284 | 87th | 2026-09-17 |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | NEW YORK, NY | 1,083,075 | 88th | 2026-09-17 |
| CORNELL UNIVERSITY | ITHACA, NY | 1,180,541 | 90th | 2026-09-17 |
Related records
- UNIVERSITY OF ROCHESTER
- GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY
- CORNELL UNIVERSITY
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- CORNELL UNIVERSITY
- DUB THERAPEUTICS INC.
- CITY COLLEGE OF NEW YORK
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
- CORNELL UNIVERSITY
- FOUNDATION FOR AIDS RESEARCH
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- NEW YORK UNIVERSITY
NihBiotechGrantPulse: records in New York NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More New York public-record feeds
New York Oil and Gas Summary Production Data Pulse in New York FEMA Hazard Mitigation Project Tracker in New York Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in New York New York College Access Challenge Grant Program Subgrantees Pulse in New York New LLCs, Corporations & Nonprofits in New York, Colorado, Connecticut & Oregon in New York New MSHA Citations at Mines & Quarries by State in New York New York Hospital Inpatient Discharges (SPARCS De Pulse in New York New York Truck Voucher Incentive Program Projects Reported By NYSERDA Pulse in New York
How to monitor BLOOD CELL TECHNOLOGIES, LLC and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like BLOOD CELL TECHNOLOGIES, LLC by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.